ESC 365 - The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes.

Open Access

The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes.

Session: The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes

Topic: Chronic Heart Failure

Speaker: Doctor A. Bayes Genis (Badalona, ES) Doctor M. Vaduganathan (Boston, Massachusetts, US)

Sponsored by Roche Diagnostics International

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speakers

Doctor Antonio Bayes Genis

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

52 presentations

12 followers

Doctor Muthiah Vaduganathan

Brigham and Women?s Hospital and Harvard Medical School, Boston, Massachusetts (United States of America)

4 presentations

1 follower

1 more presentation in this session

Q&A.

Access the full session

The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes

Speakers: Doctor A. Bayes Genis, Doctor M. Vaduganathan

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by